Author

D. K. Lukyanov

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

D. M. Chudakov· 2 shared A. Franke· 1 shared A. Komkov· 1 shared A. R. Zaretsky· 1 shared A. S. Fedosova· 1 shared B. Minasian· 1 shared D. A. Price· 1 shared D. B. Staroverov· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. M. Chudakov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Repertoire-based mapping and time-tracking of helper T cell subsets in scRNA-Seq

D. K. Lukyanov, V. V. Kriukova, K. Ladell, I. A. Shagina, D. B. Staroverov, B. Minasian, A. S. Fedosova, P. Shelyakin, O. N. Suchalko, A. Komkov, K. A. Blagodatskikh, K. L. Miners, O. V. Britanova, A. Franke, D. A. Price, D. M. Chudakov

This paper introduces TCR-Track, a method to map and track helper T cell subsets in scRNA-Seq data, revealing their clonal relationships and functional programs over time.

bioRxiv · Oct 24, 2023Immunology

Accounting for B cell behaviour and sampling bias yields a superior predictor of anti-PD-L1 response in bladder cancer

I. A. Dyugay, D. K. Lukyanov, M. A. Turchaninova, A. R. Zaretsky, O. A. Khalmurzaev, V. B. Matveev, M. M. Shugay, P. V. Shelyakin, D. M. Chudakov

The paper develops a RNA-Seq-based predictor of anti-PD-L1 response in bladder cancer by integrating B, NK, and T cell components and accounting for sampling bias.

bioRxiv · Mar 4, 2021 · PreprintImmunology